4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Strides Pharma Science Limited (STAR) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Bengaluru, India with about 3,535 employees. Its market capitalization is roughly ₹112 billion. In the fiscal year ended 2026-03-31, STAR reported ₹46.3B in revenue and ₹5.6B in net income.
Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹46.3B | ₹43.9B | ₹37.3B | ₹36.1B | — |
| Gross Profit | ₹24.6B | ₹22.6B | ₹18.5B | ₹18.6B | — |
| Operating Income (EBIT) | ₹6.2B | ₹5.8B | ₹3.2B | ₹1.4B | — |
| Net Income | ₹5.6B | ₹35.9B | (₹706M) | (₹2.0B) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹12.7B | ₹13.2B | ₹11.9B | ₹11.2B | ₹11.9B | — |
| Gross Profit | ₹7.7B | ₹7.9B | ₹7.3B | ₹6.8B | ₹6.9B | — |
| Operating Income (EBIT) | ₹1.7B | ₹1.9B | ₹1.9B | ₹1.7B | ₹1.7B | — |
| Net Income | ₹1.6B | ₹1.3B | ₹2.0B | ₹996M | ₹822M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹369M) | (₹230M) | (₹135M) | — | (₹224M) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹69.3B | ₹60.5B | ₹58.4B | ₹66.4B | — |
| Total Liabilities | ₹37.8B | ₹34.6B | ₹37.7B | ₹44.7B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive STAR viewer.
About TickerBase · Data methodology & sources · Privacy · Terms